| http://purl.uniprot.org/citations/22000720 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/22000720 | http://www.w3.org/2000/01/rdf-schema#comment | "Complement plays a dual role in the progression of systemic lupus erythematosus since it has important protective functions, such as the clearance of immune complexes and apoptotic cells, but is also a mediator of renal inflammation. To investigate this balance in a clinically relevant setting, we investigated how targeted inhibition of all complement pathways vs. targeted inhibition of only the alternative pathway impacts immune and therapeutic outcomes in NZB/W F(1) mice. Following onset of proteinuria, mice were injected twice weekly with CR2-fH (inhibits alternative pathway), CR2-Crry (inhibits all pathways at C3 activation step), sCR2 (C3d targeting vehicle) or saline. Sera were analyzed every 2 weeks for anti-dsDNA antibody levels, and urinary albumin excretion was determined. Kidneys were collected for histological evaluation at 32 weeks. Compared to the control group, all CR2-fH, CR2-Crry and sCR2 treated groups showed significantly reduced serum anti-dsDNA antibody levels and strong trends towards reduced glomerular IgG deposition levels. Glomerular C3 deposition levels were also significantly reduced in all three-treated groups. However, significant reductions of disease activity (albuminuria and glomerulonephritis) were only seen in the CR2-fH treated group. These data highlight the dual role played by complement in the pathogenesis of lupus, and demonstrate a benefit of selectively inhibiting the alternative complement pathway, presumably because of protective contributions from the classical and/or lectin pathways. The sCR2 targeting moiety appears to be contributing to therapeutic outcome via modulation of autoimmunity. Furthermore, these results are largely consistent with our previous data using the MRL/lpr lupus model, thus broadening the significance of these findings."xsd:string |
| http://purl.uniprot.org/citations/22000720 | http://purl.org/dc/terms/identifier | "doi:10.1016/j.molimm.2011.09.015"xsd:string |
| http://purl.uniprot.org/citations/22000720 | http://purl.uniprot.org/core/author | "Sekine H."xsd:string |
| http://purl.uniprot.org/citations/22000720 | http://purl.uniprot.org/core/author | "Tomlinson S."xsd:string |
| http://purl.uniprot.org/citations/22000720 | http://purl.uniprot.org/core/author | "Gilkeson G.S."xsd:string |
| http://purl.uniprot.org/citations/22000720 | http://purl.uniprot.org/core/author | "Ruiz P."xsd:string |
| http://purl.uniprot.org/citations/22000720 | http://purl.uniprot.org/core/date | "2011"xsd:gYear |
| http://purl.uniprot.org/citations/22000720 | http://purl.uniprot.org/core/name | "Mol Immunol"xsd:string |
| http://purl.uniprot.org/citations/22000720 | http://purl.uniprot.org/core/pages | "317-323"xsd:string |
| http://purl.uniprot.org/citations/22000720 | http://purl.uniprot.org/core/title | "The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition."xsd:string |
| http://purl.uniprot.org/citations/22000720 | http://purl.uniprot.org/core/volume | "49"xsd:string |
| http://purl.uniprot.org/citations/22000720 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/22000720 |
| http://purl.uniprot.org/citations/22000720 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/22000720 |
| http://purl.uniprot.org/uniprot/#_A0A0A6YWG3-mappedCitation-22000720 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22000720 |
| http://purl.uniprot.org/uniprot/#_A0A0A6YWU7-mappedCitation-22000720 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22000720 |
| http://purl.uniprot.org/uniprot/#_A0A0A6YXU7-mappedCitation-22000720 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22000720 |
| http://purl.uniprot.org/uniprot/#_A0A1B0GS59-mappedCitation-22000720 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22000720 |
| http://purl.uniprot.org/uniprot/#_E9Q3S5-mappedCitation-22000720 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22000720 |
| http://purl.uniprot.org/uniprot/#_Q32M14-mappedCitation-22000720 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22000720 |
| http://purl.uniprot.org/uniprot/#_P19070-mappedCitation-22000720 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22000720 |
| http://purl.uniprot.org/uniprot/#_Q9CVM1-mappedCitation-22000720 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22000720 |
| http://purl.uniprot.org/uniprot/#_Q9DC83-mappedCitation-22000720 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22000720 |
| http://purl.uniprot.org/uniprot/A0A0A6YXU7 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/22000720 |
| http://purl.uniprot.org/uniprot/E9Q3S5 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/22000720 |